ECOG-ACRIN Staff

October 19, 2023
Young Black woman on laptop
October 19, 2023
Categories

Now Enrolling: Social Genomics Study EAQ211 to Examine Known Biomarkers of Elevated Health Risk in Adolescent and Young Adult Cancer Survivors

Through a series of blood tests and patient questionnaires, this prospective observational study examines how exposures to trauma and other adverse life experiences alter the activity of genes, immune cells, and subsequent health outcomes
Do you like it?
0 Read more
October 19, 2023
Woman patient speaking with doctor
October 19, 2023
Categories

Now Enrolling: EA2212 for Patients with Gastric and/or Gastroesophageal Junction Cancer

This randomized phase 2 study is assessing if chemotherapy plus immunotherapy is superior to immunotherapy alone for patients with operable MSI-H/dMMR gastric and/or gastroesophageal junction cancer
Do you like it?
0 Read more
August 25, 2023
Doctor examining patient's neck
August 25, 2023
Categories

Now Enrolling: EA3211 for Patients with Squamous Cell Carcinoma of the Head and Neck

This phase 3 study of oligometastatic head and neck cancer is exploring whether it is more effective to add radiation therapy to standard immunotherapy in patients with stable disease after initial chemotherapy plus immunotherapy
Do you like it?
0 Read more
August 25, 2023
Patient with doctor reviewing tablet
August 25, 2023
Categories

Now Enrolling: EA7211/STRASS 2 for Patients with High-Risk Retroperitoneal Sarcoma

The ECOG-ACRIN Sarcoma Working Group has launched its first trial, an international collaboration to evaluate chemotherapy prior to surgery in patients with retroperitoneal leiomyosarcoma or dedifferentiated liposarcoma
Do you like it?
0 Read more
123456789